Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical Device Startup Investors in France

Last updated: Apr 2024 A list of 50 angel investors and VC funds that invest in Medical device startups based in France. We rank investors based on the number of investments they made in Medical device companies from France. We update this investor list every month.

Top 50 Medical Device Startup Investors in France

Investor	Medical Device France investments
Bpifrance	14
GO CAPITAL	11
Sofimac Investment Managers	10
Karista	10
Seventure Partners	10
Kurma Partners	8
Sofinnova Partners	8
Crédit Agricole	7
IRDI	7
Elaia	7
Idinvest Partners	6
M Capital Partners	6
Omnes Capital	6
Angels Santé	5
Finovam Gestion	5
WiSEED	5
Galia Gestion	4
iBionext	4
BNP Paribas Développement	4
Nord France Amorcage	4
Newfund	4
Auriga Partners	4
Inserm Transfert Initiative	4
Pontifax	3
ACG Management	3
Sham Innovation Santé	3
Cap Innov'Est	3
Supernova Invest	3
MD Start	3
AQUITI Gestion	3
UI Investissement	3
Crédit Mutuel Innovation	3
C4 Ventures	2
Norgine Ventures	2
NBGI Ventures	2
Carvest Crédit Agricole Régions Investissement	2
Partech	2
Daniel Caille	2
IT-Translation	2
Mérieux Equity Partners	2
Fly Ventures	2
Yann Fleureau	2
Ace Capital Partners	2
Wille Finance	2
A Plus Finance	2
Medevice	2
European Investment Bank	2
MACSF	2
TRAIL SOLUTIONS PATRIMOINE	2
Le Studio VC	2

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Series A
France, United States, Switzerland

Portfolio highlights

HawkCell — A plug-and-play solution turning human MRI into the first animal-dedicated imaging enhanced with AI algorithms. A unique MRI solution.
Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.
Docent — Docent is the first AI-powered mobile application to offer a fully-personalized experience for discovering, accessing and collecting contemporary masterpieces.

GO CAPITAL is a management company approved by the AMF and a member of AFIC. It is based in Rennes, and manages more than 130 million of assets by investing primarily in western France in innovative companies with high growth potential.

Investment focus

Biotechnology, Software, Health Care
Funding Round, Seed, Series A
France, Canada, Israel

Portfolio highlights

Genevos — Genevos specializes in integrating hydrogen and fuel cell systems in the maritime industry.
Biosency — BIOSENCY is a medical device company focused on developing smart healthcare solutions. Our first product, a connected PPG sensor system using smart data is a monitoring and prevention solution dedicated to respiratory insufficiency. Our company is based in Rennes, France. We work closely with doctors and researchers to bring to the medicalcommunity the best possible tools to help patients.
Sweetch Energy — Sweetch Energy is created to leverage most recent academic discoveries in nanotechnologies and materials in the blue osmotic energy field and combined them with the efficiency of the private sector.

Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)

Investment focus

Biotechnology, Health Care, Manufacturing
Funding Round, Seed, Series A
France, Italy, Austria

Portfolio highlights

Blue Valet — Blue Valet is a provider of valet parking-parking at airports and train stations.
Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Investment focus

Software, Biotechnology, Health Care
Seed, Series A, Series B
France, United States, Germany

Portfolio highlights

constellr — Smart Farming and Climate Monitoring from Space. At constellr, we are using cutting-edge beyond-visual imaging technology to revolutionise the way we assess crucial aspects of our planet's health.
Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
Kranus Health — Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.

Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.

Investment focus

Biotechnology, Health Care, Software
Series A, Funding Round, Series B
France, United States, Germany

Portfolio highlights

Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
Allozymes — Allozymes, Pte. Ltd. is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We developed sensitive, accurate, and generic assays for the detection of enzymatic reactions, proprietary microfluidic chips and proteomics technologies to take enzymedevelopment to the next level.
Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Series A, Series B, Seed
France, Spain, Switzerland

Portfolio highlights

Poppins — Mila merges music, technology, and neuroscience to reshape therapy into a musical experience. We create musical games for children based on neurologic music therapy methods. These games are designed to address learning dissabilities like dyslexia, providing a digital treatment at home and helping identify these conditions. Behind these games, weleverage data science and new technologies to interpret learning, language, and motor performance into a cognitive score. Our goal is to improve the process for patients receiving treatment and to reaching the vast undiagnosed majority.
Shorla Pharma — Shorla Pharma is an Irish specialty pharmaceutical company. It is growing portfolio brings accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical impact.
Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

Cure51 — Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features and find new drugs to cure Cancer.
Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas

Credit Agricole is a banking corporation with focuses on corporate and investment banking, retail banking, and savings management. Crédit Agricole Group is a responsible, helpful bank serving 49 million customers, 7.4 million mutual shareholders, and 1.2 million shareholders. Crédit Agricole Group supports its customers in their plans and projectsin France and around the world, through its operations in all segments of the market including insurance, real estate, payment systems, asset management, leasing and factoring, consumer finance, and corporate and investment banking. Crédit Agricole also stands out for its dynamic, innovative corporate social responsibility policy serving the economy. This policy is based on a pragmatic approach that permeates throughout the entire Group and engages all its employees. Its recent inclusion in the Vigeo-NYSE Euronext extra-financial indices is recognition of this engagement.

Investment focus

Software, Manufacturing, Health Care
Funding Round, Seed, Debt Financing
France, United States, Italy

Portfolio highlights

Loop Dee Science — Loop Dee Science is a DNA startup that makes molecular biology diagnostics. They develop and manufacture field genetic analysis kits for the detection of pathogen DNA and RNA. Their automatic field analysis device is a multi-spectral analysis device that provides local output and can also be connected via USB or Bluetooth.
Technique Solaire — Technique Solaire specializes in the distribution of photovoltaic energy for individuals and businesses as corant from solar panels.
Arkeon Energy Systems — Arkeon Energy Systems develops hermodynamic cycles and thermal stages to meet heating, air conditioning, and electricity needs.

IRDI Gestion is a private equity and venture capital institution.

Investment focus

Health Care, Software, Biotechnology
Funding Round, Series A, Series B
France

Portfolio highlights

REEV — REEV motorizes medical orthoses to help millions of people affected by gait disorders to walk, stand, sit and climb stairs with greater ease every day.
Mon Chasseur Immo — Mon Chasseur Immo is a Real Estate, based in Languedoc Roussillon.
Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.

Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Series B
France, United States, Spain

Portfolio highlights

AQEMIA — Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovative therapeutic molecules with better chances of success.
Vibe — Advertise your brand on CTV & OTT content with Vibe's self-serve ad platform to target hundreds of channels & networks and reach millions of households.
Composable Prompts — Composable Prompts helps enterprises deploy LLM technology, with governance, collaboration, orchestration, and a unique virtualization engine.

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Investment focus

Biotechnology, Software, Health Care
Series B, Series A, Funding Round
France, United States, Spain

Portfolio highlights

Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
BreezoMeter — BreezoMeter offers personalized air quality & pollen data as well as active fire alerts with worldwide coverage & accuracy down to the street level.

M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.

Investment focus

Health Care, Food and Beverage, Software
Funding Round, Seed, Series A
France, United States, Canada

Portfolio highlights

Ellona — Ellona offers advanced solutions for odor control and air quality monitoring, providing customized industrial applications. Discover our innovative products and services.
Olino — Olino is the insurance for tomorrow's SME. A digital service, a turnkey solution tailored to VSBs and SMEs, meeting all insurance needs.
Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.

Omnes, "Powering Entrepreneurs" is a Leading private equity firm dedicated to energy transition and innovation.

Investment focus

Software, Biotechnology, Health Care
Series A, Funding Round, Series B
France, United States, Belgium

Portfolio highlights

Planet A Foods — The chocolate revolution is here. 100% cocoa-free and unbelievably delicious. We call it QOA. You need to try it!
Quandela — Quandela is an expert in the fabrication of performing devices for the research in quantum photonics and quantum information. They fabricate unique solid-state sources of quantum light. These sources bring a new revolution in quantum technologies based on light.The company's single-photon source device combines photonics and semiconductorquantum dots for quantum communication, computation and sensing and permits to collect the emitted single-photons with exceptional efficiency at high rates, enabling researchers to strongly reduce the charge noise decoherence and assist in the emission of identical photons with fidelity close to unity, an essential requirement for the development of the most advanced quantum applications.
Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.

Angels Santé is a networking site for investors and companies in the health sector.

Investment focus

Health Care, Medical Device, Biotechnology
Seed, Funding Round, Angel
France, India, United States

Portfolio highlights

Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
Odimma — Empowering personalized immunotherapy to treat cancer
SeaBeLife — SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.

Finovam Gestion is an investment company approved by the AMF which takes minority stakes in innovative SMEs with high growth potential.The company, which manages €50M, invests in companies that have developed innovative offers in the following target sectors: Information and Communication Technology, Health and Biotechnologies, Agro-resources andEcotechnologies.Finovam Gestion has built solid relationships with the ecosystem of entrepreneurship (Industrials, Poles of Competitiveness, Incubators, Accelerators, Universities, and Research Centers) in all the sectors that we target in order to be able to source and do emerge the best companies.Among our investors (LPs), we can count BPI France, manufacturers (ADEO, LESAFFRE, TEREOS), banks (BNP Paribas, Caisse d´Epargne, Crédit Agricole) and the Haut de France and Grand-Est regions.

Investment focus

Information Technology, Software, Medical Device
Seed, Funding Round, Series A
France, United States

Portfolio highlights

Selvitys — Selvitys is a fully automated method for designing, delivering, and analyzing online surveys.
Charlie solutions — Charlie solutions offers the traceability system technologies to optimize their management system of the equipment.
Osiris agriculture — Osiris desires to make agriculture more sustainable while also assisting farmers in living more peacefully. The business is working on a robot that will assist farmers in growing potatoes, sugar beets, and field crops. This four-wheeled robot will be able to automate and improve functions such as watering, fertilizing, weeding, and crop protection.

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

Investment focus

Software, Manufacturing, Biotechnology
Seed, Funding Round, Equity Crowdfunding
France

Portfolio highlights

Dianosic — Dianosic was founded in 2017 and develops innovative solutions in the field of ENT (Ear, Nose & Throat), a $50 billion, double digit growth, and still largely underserved market. Our startup operates right at the frontier between Medtech and Biotech, as we see tremendous opportunities for drug-device combinations in this specialty. The projectoriginates from the ENT Department from the University Hospital of Strasbourg, where unmet clinical needs have been identified. Our main focus areas are Chronic Rhinitis, Chronic Sinusitis and intranasal bleeding (Epistaxis). Noteworthy, Dianosic has a strong French and German footprint in R&D and manufacturing.Dianosic’s strategic goal is to establish new standards of care in Chronic Rhinitis and Chronic Sinusitis with its drug-eluting Active Resorbable Scaffold (ARIS). This drug-device combination ARIS platform, developed with world renowned resorbable polymers experts, has the potential to establish new treatment paradigms. Moreover, our ARIS platform creates immense opportunities to create other verticals, especially in the field of chronic migraine and facial pain.Beside this, Dianosic commercialize an Asymmetric Intranasal inflatable solution (CAVI-T) for the treatment of intranasal bleeding, a widespread condition in ENT that affects 10% of the population. This CE marked and FDA registered technology addresses a clear unmet need and demonstrated our ability not only to develop a differentiated technology in record time, but also to successfully transition from R&D to Sales. We are currently present in relevant markets in EU and paving the way to launch in the U.S. in the mid term. Noteworthy, since our main call point is the ENT, CAVI-T prepares the ground for our upcoming ARIS platform.
VistaCare — "Making Difficult Wounds Easy" : VistaCare is a Breakthrough and non-invasive Medical Device designed for treatment during the critical phases of the wound.
BiPER Therapeutics — BiPER Therapeutics : First-In-Class Therapeutics to Treat Cancer. Biotech company founded in 2021 to develop and commercialize novel therapeutics.

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

Investment focus

Software, Manufacturing, Biotechnology
Funding Round, Series A, Seed
France, United States

Portfolio highlights

Wizaly — Unlock the Power of Marketing Analytics at Wizaly.com: Optimize Your Marketing Campaigns, Maximize ROI, and Understand the Customer Journey. Discover actionable
Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.

iBionext is a unique healthcare fund created within a proven breakthrough innovation accelerator. Their companies are based in a single location named “Passage de l’innovation” in Paris, France. Over the past 4 years, we have created 7 companies that have raised over 250M € and created 103 highly qualified jobs.

Investment focus

Medical Device, Artificial Intelligence, Biotechnology
Funding Round, Series A, Seed
France

Portfolio highlights

Prophesee — REVEAL THE INVISIBLE with the world's most advanced neuromorphic vision system, inspired by human vision and built on the foundation of neuromorphic engineering. PROPHESEE gives Metavision to machines, revealing what was previously invisible to them.
GrAI Matter Labs — GrAI Matter Labs has created the fastest edge AI processor for machine vision in robotics, AR/VR, drones and more. It achieves ultra-low latency at low power by leveraging sparsity.
Tilak Healthcare — Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases.

BNP Paribas Développement is the investment arm of BNP Paribas that specializes in SME development. It specializes in second stage, mezzanine, bridge, acquisition, leveraged buyouts, management buyouts, recapitalization, special situations, and privatizations transactions.The firm considers investments in manufacturing, service industries,medicine, electronics, energy, chemistry, new materials, industrial automations, industrial goods and services, transportation, consumer goods, commerce and distribution, buildings and public works, wholesale retail, biotechnology, telecommunications, and information technology sectors.BNP Paribas Développement was established in 1988 and is based in Paris, France.

Investment focus

Software, Information Technology, Health Care
Funding Round, Series A, Series B
France, Germany, The Netherlands

Portfolio highlights

Pandobac — Pandobac, comes to offer a response to packaging waste generated by the transport of fresh produce. In the Paris region, around 300,000 boxes of polystyrene, cardboard, wood and plastic are thrown away every day. They are used to transport food goods from the Rungis market to merchants. Pandobac is a complete eco-delivery solution for wholesalersand producers. It includes the provision of sustainable transport bins and a support service to ensure their long-term reuse. This solution fits directly into the current delivery cycle, replacing disposable packaging with durable bins and taking advantage of delivery trucks returning empty of their tour.
ANOZR WAY — Human risk management platform for monitoring, alerting and recommending remediation of employee and manager vulnerabilities.
GREENERWAVE — We shape electromagnetic wavesHaving its roots in deep wave physics, Greenerwave develops revolutionary solutions to solve connectivity and mobility toughest challenges.

Nord France Amorçage is a regional co-investment fund, exclusively supported by the Hauts-de-France Region. This seed fund has been involved since 2013 in financing innovative businesses that create jobs and add value to the region. In 6 years, NFA has more than 50 participants spread across the region.

Investment focus

Software, Information Technology, Health Care
Seed, Funding Round, Series A
France, United States

Portfolio highlights

Niryo — Niryo is a deeptech company designing and assembling collaborative robots. We focus deliver affordable and intuitive 6 axis collaborative robots for the education and industrial market. Discover our latest technologies through NED2 robot and an entire ecosystem to discover robotics, AI, industry 4.0 and more
NeoCem — NeoCem creates, manufactures, and promotes a variety of low-carbon cements for the building industry. They have developed a novel procedure that permits the utilization of raw materials sourced from recovery sectors.
Selvitys — Selvitys is a fully automated method for designing, delivering, and analyzing online surveys.

Newfund is a $300M entrepreneurial VC firm dedicated to pre-seed and seed investments in France and North America, in companies driving global change. The company is always looking for founders who are driven to realize a vision that will significantly alter the world in which we live. In order to appreciate what entrepreneurs are creating andutilize their strengths, Newfund aims to comprehend entrepreneurs as unique individuals.

Investment focus

Software, Information Technology, SaaS
Seed, Funding Round, Pre-Seed
France, United States, Canada

Portfolio highlights

Neo Earth — We specialize in developing high-yield natural microalgae strains, tailored for producers seeking to enhance their productivity.
Bolero — Invest in the music rights of your favourite songs and get royalties on Bolero, the all-in-one marketplace to invest in Song Shares. Invest in music today!
Clever Carnivore — Clever Carnivore is a cell-cultured meat startup that uses stem cell biology, recombinant protein, and bioengineering to create cost-effective lab grown meats. With the company's high-efficiency model, cruelty-free, environmentally friendly, and cost-competitive technology it aims to produce sausage, burgers, and chicken nuggets.

Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
France, United States, Switzerland

Portfolio highlights

Patrowl — Identify and harden your External Security Posture with the leader. Let us manage time-consuming tasks and focus on remediation
Exeliom — Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs. Their mission is to harness the therapeutic potential of gut microbiota to enable people to lead longer and healthier lives. They are committed to developing the next generation of probiotics: innovative microbial therapies.Exeliom develops anew class of medicines called Live Biotherapeutics based on their growing understanding of the central role of the microbiota in the immune system.The company was founded in 2016 and is headquartered in Dijon, France.
Vade Secure — Vade is a global leader in predictive email defense, protecting 1 billion inboxes worldwide. AI-based email security for Microsoft 365.

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about â‚¬4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.

Investment focus

Biotechnology, Medical, Health Care
Series A, Series B, Seed
France, Switzerland, United States

Portfolio highlights

Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
VectivBio — We Are Ironwood
Aelis Farma — Aelis Farma is a pioneer in the development of signaling specific therapeutics that target GPCRs (and more specifically the CB1 receptor which is one of the most expressed GPCRs in the brain). GPCRs are the target of most therapeutic drugs. This family of receptors has the characteristics to activate several and often opposing signaling pathways.Unfortunately, most of the drugs acting on GPCRs either block or stimulate the entire signaling activity of the receptor resulting in unwanted and sometimes unacceptable side effects.

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Israel, France

Portfolio highlights

Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.

Smalt Capital anciennement ACG Management, est un acteur majeur depuis plus de 20 ans

Investment focus

Software, Health Care, Biotechnology
Funding Round, Seed, Series A
France, Madagascar

Portfolio highlights

Kamp'n — Partenaire de croissance Facebook Ads & Google Ads
Little Cigogne — Little Cigogne is reinvents the shopping experience for children.
My Coach Football — My Coach Football allows you to manage and organize the daily operations of your football team, day after day, season after season. Designed to answer amateur and professional coaches’ needs, the platform centralizes all of your squad’s information and allows to gain time and efficiency. In a single click, you can manage players and their personalinformation, the preparation of training and games, but also individual and collective statistics. Season after season, you keep all those data and hence enjoy an optimum tracking of your team’s progression.

Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth anddevelopment phases of their life cycle.

Investment focus

Biotechnology, Medical Device, Medical
Series B, Series A, Funding Round
France

Portfolio highlights

Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.

Cap Innov’Est is a 36M€ tri-regional fund dedicated to investments in young innovative start-ups. Cap Innov’Est was launched in July 2014 and has already invested in 13 start-ups. Cap Innov’Est is supported by Fonds National d’Amorçage, the 3 Regions Alsace, Bourgogne and Franche-Comté, SAFIDI, caisses d’épargne d’Alsace etBourgogne/Franche-Comté, BNP Paribas et CIFC

Investment focus

Biotechnology, Pharmaceutical, Health Care
Seed, Series A, Funding Round
France, United States

Portfolio highlights

VistaCare — "Making Difficult Wounds Easy" : VistaCare is a Breakthrough and non-invasive Medical Device designed for treatment during the critical phases of the wound.
Opencell Software — Increase recurring revenue. Opencell's platform simplifies launch, scales with your business, and streamlines billing. Optimize sales cycles, improve customer experience, and gain valuable revenue insights. Start today!
Rhythm Diagnostic Systems — Many of our team have worked together on different projects and in different companies over the last 30-plus years. We are experienced technology, medical, health care and biotech professionals, with long, successful histories in Silicon Valley and elsewhere.

we believe that top scientists and ambitious entrepreneurs can build a world where cutting-edge technologies shape the next generation of industry leaders.

Investment focus

Health Care, Medical Device, Biotechnology
Series A, Funding Round, Seed
France, Switzerland, United States

Portfolio highlights

EODev — EODev develops and industrialises sustainable, reliable and accessible energy solutions using hydrogen.
Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.
Cambridge Mechatronics — Cambridge Mechatronics (CML) is a high technology design and engineering company based in Cambridge, UK. We specialise in pioneering and developing cutting-edge mechatronic platform technology from concept to mass production. We achieve this through technology licensing or partnerships with global manufacturing corporations. Our intellectualproperty portfolio consists of over 100 granted patents that we can exploit.

MD Start is an incubator and fund dedicated to medical technologies. MD Start creates, develops, and operates medical projects, turning them into new companies with both strategic and hands-on approaches, in order to bring them to investment stage and commercial development.

Investment focus

Medical Device, Health Care, Biotechnology
Seed, Series B
France

Portfolio highlights

Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.
HEPTA Medical — HEPTA Medical develops a sensor, embedded into a bronchoscopic or percutaneous ablation catheter, which provides temperature-based feedback. This enables real-time dosing to precisely target and ablates pulmonary nodules, the precursor of lung cancer, without the need for surgery or radiation.
Gradient Denervation Technologies — Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University.

Acteur incontournable du capital-investissement en Nouvelle-Aquitaine

Investment focus

Biotechnology, Software, Health Care
Funding Round, Seed, Series A
France, United States

Portfolio highlights

Dionymer — Dionymer is putting money into the circular economy by creating a method that uses microorganisms to convert industrial organic waste into biodegradable polyhydroxyalkanoates, or PHA, polymers.
Pony — Instant city bike hire
ALOGIA Groupe — ALOGIA Groupe offers preventive health responses to senior people at home through care management and innovative services.

Since 1967, the UI brand embodies a partnership with companies. Actor of the economy, UI has accompanied more than 120 SMEs over the last fifteen years, investing more than 550m € and giving substance to their development projects. Combining experience and corporate culture, UI has established itself as an involved and independent partner, able tocount on its shareholder leaders to favor, independently, the sustainable performance of the SMEs it accompanies.

Investment focus

Manufacturing, Health Care, Software
Private Equity, Seed, Series A
France, Canada, United States

Portfolio highlights

Doctibike — Battery renovation expert, Doctibike offers many innotative services such as branded battery sale, battery reconditioning, after sales service… They care about being here for our customer and provide an expert and tailored response.
Recyc'Elit — Recyc'Elit has developed a polyethylene terephthalate technology that allows polyesters to be broken down into original constituent atoms while using very little energy.
Latitude — Venture Orbital Systems provides a tailor-made service for NanoSat & CubeSat operators.

Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.

Investment focus

Software, Health Care, Biotechnology
Funding Round, Series A, Series B
France, United States, Canada

Portfolio highlights

Quandela — Quandela is an expert in the fabrication of performing devices for the research in quantum photonics and quantum information. They fabricate unique solid-state sources of quantum light. These sources bring a new revolution in quantum technologies based on light.The company's single-photon source device combines photonics and semiconductorquantum dots for quantum communication, computation and sensing and permits to collect the emitted single-photons with exceptional efficiency at high rates, enabling researchers to strongly reduce the charge noise decoherence and assist in the emission of identical photons with fidelity close to unity, an essential requirement for the development of the most advanced quantum applications.
HarfangLab — HarfangLab develops a hunting software to boost detection and neutralization of cyberattacks against companies endpoints. They plug their platform to third-party cybersecurity solutions to enhance visibility on your system. Their specialists have led many operations of defensive and offensive cyberwarfare for ANSSI (the French National Agency forthe Security of Information Systems), the French ministry of Defense and major cybersecurity companies.
Latitude — Venture Orbital Systems provides a tailor-made service for NanoSat & CubeSat operators.

C4 Ventures is a leading venture investor in Europe founded by Pascal Cagni. Based in London and Paris, we typically invest in startups based in Europe and later stage startups seeking to expand into European markets.

Investment focus

Software, E-Commerce, Internet
Series A, Seed, Funding Round
United States, France, United Kingdom

Portfolio highlights

Allison — Allisone deep learning a subset of artificial intelligence at to produce the most reliable, durable, and precise cutting edge software. Deep learning is a learning method that derives level features from data using neural networks set up in consecutive levels of processing. The artificial intelligence team works hard to bring its most reliable andsecure technology the most creative knowledge and most importantly to become the most used and identified machine intelligence in the dental field. By displaying annotated X-ray images to AI system it is able to learn to quantify them instantly and reproduce its pattern of having read the features to provide therapists with a second read of the pictures.
Remedee Labs — 1.5 billion people worldwide suffer from chronic pain and over half of them are not satisfied with their care. Remedee Labs aims to give these patients a new life. Based on 10 years of pre-clinical and clinical research, Remedee Labs has developed the first endorphin stimulator for personal use. Building on the experience of its clinicalpartners, the company now uses its unique technology to offer the first patient-centered digital service platform for chronic pain management, working alongside medical practitioners. Remedee Labs initial focus is helping patients with fibromyalgia, and plans extend the Platform offering to other chronic pain conditions in the coming future.Founded in 2016, Remedee Labs announced in 2019 that it had raised 12 million dollard from investors, including HCVC, Habert Dassault Finance, Partech, Supernova Invest and C4 Venture.
Kessel — Kessel platform enables to publish texts and newsletters, send them to subscribers, and set up paid subscriptions.

Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US. Norgine Ventures is backed by Norgine, a fully integrated, private,European healthcare company with over 110 years of experience in the pharma space.Norgine Ventures has full access to Norgine’s technical capabilities for evaluating investment opportunities, although the business is aimed at achieving a financial return rather than funding opportunities of strategic interest to Norgine.To date, Norgine Ventures has invested in a number of businesses, including specialty pharma, diagnostic and medical device companies, at various stages of their life cycle, both in Europe and in the US.

Investment focus

Health Care, Medical Device, Biotechnology
Funding Round, Debt Financing, Series A
France, United Kingdom, United States

Portfolio highlights

ImaginAb — ImaginAb is a biotechnology company focused on developing a new class of highly targeted diagnostic imaging agents based on engineered antibody fragments. ImaginAb's platform technology enables the rapid engineering of antibodies into fragments that retain the parental antibody but are immunologically passive and kinetically-optimized forclinical imaging. This combination of superior specificity and kinetics enables ImaginAb to generate agents that can address the unmet needs in diagnosis and patient selection for therapeutics.
PathoQuest — PathoQuest provides biosafety assays based on next-generation sequencing (NGS) for biologics quality testing. GMP biotesting for biopharmaceuticals. Learn more.
Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.

NBGI Ventures is a venture capital fund focused on investing in seed, early, and middle stage medical technology companies. It was established in 2001 and is headquartered in London, United Kingdom.

Investment focus

Health Care, Biotechnology, Medical Device
Series B, Series A, Funding Round
France, Denmark, United States

Portfolio highlights

Reverse Medical — Reverse Medical is a commercial-stage medical device company focused on revascularizing patients experiencing Acute Ischemic Stroke.
SuperSonic Imagine — SuperSonic Imagine SA develops and manufactures ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company provides Aixplorer, an ultrasound system for breast lesion imaging; and ShearWave, an ultrasound technology platform for quantitative elastography. It offers its products through its offices and a networkof distributors in France, Belgium, Austria, Croatia, Poland, the Czech Republic, Singapore, Taiwan, Thailand, Malaysia, Hong Kong, Lebanon, Germany, the United Kingdom, and the United States. SuperSonic Imagine SA was founded in 2005 and is based in Aix-en-Provence, France with additional offices in Germany, the United States, and the United Kingdom.
Quanta — OG Home description

Carvest, a subsidiary of Credit Agricole Regional Banks, assists regional businesses in the implementation of capital development and capital transfer.

Investment focus

Food and Beverage, Manufacturing, Software
Private Equity, Funding Round, Series A
France, Oman, United States

Portfolio highlights

Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
Dammann Frères — Dammann Frères is an e-commerce platform for gift sets, teabags, and accessories.
Leygatech — Leygatech provides flexible film packaging, equipped with functionalities compatible with the requirements of the circular economy and intended for the agri-food, pharmaceutical, and pharmaceutical markets.

Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.

Investment focus

Software, E-Commerce, Financial Services
Series A, Seed, Series B
United States, France, Germany

Portfolio highlights

scnd — The marketplace solution to sell services online. Start selling services directly or through a marketplace with third party providers and scale infinitely.
Nomad Homes — Nomad Homes provides concierge real estate hunting services and technology to match the specific needs of buyers in Dubai with their dream home.
Second — The marketplace solution to sell services online. Start selling services directly or through a marketplace with third party providers and scale infinitely.

Daniel Caille

Investment focus

Elderly, Medical, Software
Series A, Pre-Seed, Funding Round
France

Portfolio highlights

HypnoVR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
Medylink —
CetteFamille — CetteFamille is an economical alternative to retirement homes in France. It is a French network of professional and accredited families to welcome the elderly.CetteFamille is a warm, economical and tailor-made alternative to the retirement home. CetteFamille is a site of connection and a company of services to the person allowing seniors to finda trained and selected family close to home. CetteFamille offers seniors and their families an offer of contact and a follow-up service to carry out all the administrative procedures.On www.cettefamille.com, caregivers of seniors can register to meet a family available nearby. The teams at CetteFamille are responsible for contacting them to study the request and ensure a meeting with the family most appropriate to meet his needs.

IT-Translation: investor and co-founder of digital technology start-ups developed from research

Investment focus

Software, SaaS, Artificial Intelligence
Seed, Funding Round, Series A
France

Portfolio highlights

Accelad — AccelaD is the company behind Raphton™, an innovative software assistant for electronic design. Raphton™ enables hardware designers to work 10 times faster and improve the performance of their designs, bringing a breakthrough in competitiveness and creating new opportunities for electronics manufacturers.
AntsRoute — AntsRoute is a cloud-based route planning & optimization software developed by the French startup Antsway in 2015. The solutions help professionals to create optimal delivery, pick-up and multi-stop routes. The routing software makes it easier to smartly schedule appointments, optimize daily routes, automate dispatch to drivers, track theirprogress in real-time and keep customers updated with SMS alerts. The best software to increase stops per route, cut down transport costs and planning time.
Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.

Mérieux Equity Partners (“MxEP”) is a management company dedicated to venture, growth and LBO investments in the healthcare and nutrition sectors. MxEP actively supports entrepreneurs and industrial companies with differentiated products and services, by providing privileged access to its expertise and international network. MxEP currently managesmore than €600m AUM and has recently launched a new vehicle MP3 of €350m dedicated to growth/LBO.

Investment focus

Biotechnology, Health Care, Medical
Series A, Private Equity, Funding Round
France, Sweden, Belgium

Portfolio highlights

Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Mablink Bioscience — Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC).
Broken String Biosciences — Our platform accelerates the characterisation of novel gene editing technologies to unlock the next wave of cell & gene therapies.

Fly is a first check VC for technical founders solving hard problems. We invest from day-zero to seed, backing founders from all over Europe.

Investment focus

Software, Artificial Intelligence, Machine Learning
Seed, Series A, Pre-Seed
United Kingdom, Germany, United States

Portfolio highlights

FERNRIDE — Fernride enables automated, sustainable logistics by combining the skills of remote drivers with autonomous technologies.
Lakera AI — Lakera Guard empowers organizations to build GenAI applications without worrying about prompt injections, data loss, harmful content, and other LLM risks. Powered by the world's most advanced AI threat intelligence.
Martian Lawyers Club — Martian Lawyers Club takes game personalization to the next level with the help pf generative AI.

Yann sets the vision and strategic direction for Cardiologs and is the guardian of company culture. He is a frequent speaker at industry conferences and is recognized as a thought leader in the application of AI in healthcare. Yann graduated with a degree in Computer Science and Biology from Ecole Polytechnique Paris (X) and the Silicon ValleyInnovation and Entrepreneurship program at UC Berkeley.He was recently named one of MIT Technology Review's Innovators Under 35 in Europe and BNP Paribas European Innovator of the Year. Yann is passionate about the intersection of new technology & clinical practice and is excited to be building a leading company that will help usher in a new era for healthcare worldwide.

Investment focus

Health Care, Medical Device
Series A, Series B
France

Portfolio highlights

Sonio — With Sonio, prenatal ultrasound professionals improve each step of their workflow. Democratizing high-quality care through medical-grade AI.
Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.

Ace invests with a sector-focused approach, active in Industrials and Technology. The firm builds partnerships with large corporates (including Airbus, Safran, Dassault Aviation, Thales, EDF, Naval Group, Sopra Steria), which invest in its funds and maintain an ongoing dialogue with the firm, enabling Ace to take a differentiated approach toinvesting. Ace provides capital for businesses going through transformation, with the ability to invest with a variety in growth, buyout, and restructuring situations. We focus on companies with a proven expertise in their market, and with high and resilient intrinsic value, but which require transformation to deliver on their potential. We act as a strategic partner to management as we transform operations, and restructure/grow the business both organically and through external growth. Ace is active throughout Europe and North America. The firm has offices in Paris, Toulouse, Bordeaux and Montreal, and accesses the global network of Tikehau Capital offices (London, Milan, Madrid, Brussels, New York, Singapore, Tokyo and Seoul). Investment strategies overview: - Growth Capital: investment in high/hyper growth companies raising money in Series A through C, active in the Cybersecurity and Digital Trust verticals o Investment amount: up to €50m o Sector of focus: Technology (e.g. Cybersecurity, Digital Trust) - Support Capital: development capital / special opportunities (minority or control) investments in companies requiring capital to stabilise and or grow operations o Investment amount: up to €50m o Sector of focus: Industrials (e.g. Aerospace, Defence) - Platform Capital: development capital / special opportunities (minority or control) investments in companies requiring capital to stabilise and or grow operations o Investment amount: €50-200m o Sector of focus: Industrials (e.g. Aerospace, Defence)

Investment focus

Software, Manufacturing, Cyber Security
Series A, Funding Round, Series B
France, Germany, Belgium

Portfolio highlights

3NUM — 3NUM Shield is the first Web3 mobile number minted as a NFT that protects your identity while providing private, secure messaging.
Satys — Satys Sealing & Painting offers the aviation and rail industry unique services resulting from its in-house team of painting & sealing experts, professionally trained by the Satys Training Academy. Furthermore, dedicated state-of-the-art painting facilities worldwide enable Satys to provide qualiy services and customer proximity.
Jscrambler — Jscrambler is the leading client-side security solution for JavaScript in-app protection and real-time webpage monitoring. Start your free trial today!

An international, Swiss-based family office, focusing on private equity (venture & buy-out), real estate and listed assets.

Investment focus

Health Care, Biotechnology, SaaS
Seed, Series A, Series C
Germany, Switzerland, France

Portfolio highlights

Beedeez — Reinvent your company's professional training with the Social Learning Platform.
Instagrid — Instagrid creates software-defined battery systems for advanced portable power supplies.
BOX ID Systems — BOX ID Systems develops and offers an end-to-end location & process mining solution to cost effectively track millions of logistics assets digitally throughout the industrial supply chain across Europe and the World - including site-to-site, on-premises and indoor buildings digital twin of supply chain processes. The system is built on aspecialized analytics software platform, sensorik tracking devices and efficient data-, device- and user-management tools, including functions to support process automation and optimization. Industrial and automotive production customers benefit from making their logistics processes more efficient and cost optimized, with 100% transparency within their critical processes throughout the entire supply chain.

A Plus Finance, which is headquartered in Paris (France), is an independent trust company specialising in the management of Common Investment Fundsfor Innovation (FCPI) and Proximity Investment Funds (FIP). A Plus Finance is involved in all innovative sectors, particularly in the IT, media and security fields.The A Plus Finance team includesfinanciers and entrepreneurs, thus providing companies with both an awareness of the daily constraints of management and a long-term perspective on the development of their business. Managing funds amounting to nearly â‚¬220m, A Plus Finance invests between â‚¬1 million and â‚¬4 million per project.per

Investment focus

Software, E-Commerce, Telecommunications
Series A, Funding Round, Series B
France, United States

Portfolio highlights

Futura gaia — Futura gaïa is a food production company.
Gaiago — Gaiago is an agtech company that produces soil improvement tools.
La Belle Vie — La Belle Vie is an online grocery based in Paris, France. It sells basic groceries, organic stuff, meat, fish and vegetables. It has developed all its tools from scratch, including its ERP, a warehouse management service and a delivery management service.

Medevice focuses on investing in Medtech and e-health innovation projects. Its team has extensive experience in the fields of medical technology and e-health. The firm is composed of entrepreneurs specialized in healthcare and who have created and/or worked in healthcare companies. This not only allows them to better understand the potentialof the projects presented but also to better support the companies when they face challenges.

Investment focus

Medical Device, Health Care, Medical
Seed, Series A
France

Portfolio highlights

Dyameo — Dyameo develops single-use endoscopic probes for the instant detection of cancer cells.
IMACTIS — IMACTIS is specialized in computer assisted interventional radiology. IMACTIS develops and markets innovative solutions to assist interventional radiologists during minimally invasive needle procedures (biopsies, tumor ablations, vertebroplasties, infiltrations, drainages...). The objective is to increase accuracy and safety, facilitate complexprocedures, reduce the length of procedures, decrease the number of controls and improve patient treatment.

European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.

Investment focus

Biotechnology, Health Care, Software
Debt Financing, Post-IPO Debt, Funding Round
France, Germany, The Netherlands

Portfolio highlights

Eldrive — The largest charging point operator in Eastern Europe | Our network is expanding rapidly yet our focus is fixed on renewables, for a greener future. We provide AC & DC charging across Bulgaria, Romania and Lithuania.
ABN AMRO Bank — Als bank leggen wij de focus op inclusiviteit, duurzaamheid, sociaal ondernemen, innovatie, dagelijkse bankzaken en meer.
Enel Green Power — Enel Green Power is the company that deals with renewable energy from every perspective: from direct sales through PPA, to commitment at the forefront with its plants worldwide.

Mutuelle d'Assurance du Corps de Santé Français (MACSF) is the provider of insurance to health professionals. MACSF protects and accompanies 950,000 members of all medical and paramedical specialties, offering professional and personal solutions in insurance, savings, financing, and pensions. Its products and services meet the real needs ofits members by accompanying them in the evolution of their profession and their projects.MACSF was founded in 1935.

Investment focus

Health Care, Artificial Intelligence, Software
Series A, Funding Round, Series C
France, Spain, Ecuador

Portfolio highlights

DocCity — DocCity LifeSciences creates and provides outstanding spaces to house cutting-edge healthcare businesses. DocCity provides clinicians with state-of-the-art, fully furnished health spaces with roomy, well-lit, and digitally equipped consultation rooms and reception areas.
Gleamer — Gleamer develops an AI-powered software to enhance radiologists’ productivity.
Singulier — The new guard of strategy firm

Le site officiel de Sigma Gestion, Paris.

Investment focus

Manufacturing, Software, Medical Device
Funding Round, Seed, Pre-Seed
France

Portfolio highlights

Tesalys — Tesalys is a French company with an international presence that develops, manufactures, and markets on-site solutions for the pre-treatment by sterilisation of waste from healthcare activities with infectious risks (HCW). Our systems are part of an ecological approach by offering an alternative to waste collection and incineration, reducing CO2emissions.Tesalys solutions are compact, simple to deploy and use. Manufactured in France, they are approved by the strictest European, US and international standards. They are specially intended for hospitals, medical centres, haemodialysis facilities, laboratories, research centres.STERIPLUS™ and STERISHRED® systems shred and treat the infectious waste by steam sterilisation/decontamination. After treatment, the infectious waste is converted into harmless waste that can be disposed of like ordinary waste. Our systems are designed to be installed at the place of waste generation, reducing personnel exposure, environmental risks and costs associated to the management of infectious waste.Our shredder-sterilizers have treatment capacities ranging until 100 kg per hour of infectious waste, depending on the model.
Digitiz.me — Digitaliz.me offers consumers new digital service offerings are earning more money. It offers a solid and appealing hardware offer along with a flexible software package for retailers and large accounts. It provides services like click and collect, smartphone apps, interactive terminals, vending machines, and other linked refrigerators.
eCential Robotics — eCential Robotics facilitates minimally invasive surgery in routine clinical practice, supporting the development of day surgery, providing significant benefits to patients, hospitals, clinics and healthcare systems.

Le Studio invests in disruptive European early-stage start-ups.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Series A, Pre-Seed
France, Italy, United States

Portfolio highlights

FairMoney — Digital banking and Instant Loans in Nigeria providing collateral-free personal loans, a bank account with free bank transfers, and zero convenience fee on b...
Proportunity — Proportunity is a technology-driven mortgage lender. The company pushes the edge on real estate data-driven investment insights. It uses machine learning to accurately forecast house prices and up-and-coming areas, providing loans to buyers looking to purchase homes in forecasted high-growing areas.Vadim Toader and Stefan Boronea startedProportunity in 2016, which is headquartered in London, England.
Foxintelligence — At foxintelligence, they think data is the first and necessary step to solve any problem. Their mission is to empower decision-makers with data to improve the way societies and companies work. Foxintelligence delivers the best insights on the latest European ecommerce trends, by unlocking intelligence from hundreds of merchants and thousands ofbrands e-receipts. They provide the most reliable insights available for e-commerce while helping consumers save both time and money.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate